Breast Cancer
News
Comorbidities drive excess mortality after breast cancer diagnosis in childhood cancer survivors
A retrospective analysis found that, among matched breast cancer patients, childhood cancer survivors had a more than doubling of all-cause...
News
Racial, age disparities confirmed in triple-negative breast cancer
In a cohort of more than a million breast cancer cases, likelihood of having a tumor with the TNBC phenotype was roughly twice as high for black...
News
Increased cancer death linked to radioactive iodine therapy
News
Breast density alone should not prompt supplemental imaging discussions
News
CVD risk upped in postmenopausal breast cancer survivors
Overall, breast cancer patients had significantly higher HSP60 levels and lower HSP70 levels than those of their cancer-free peers.
Conference Coverage
APHINITY trial: Biomarker analysis IDs predictive, prognostic factors
CHICAGO – Higher levels of several immune markers confer better prognosis in HER2-positive breast cancer patients treated with trastuzumab and...
Article
Chemo-free neoadjuvant approaches emerge in NSCLC and breast cancer
Dr. Alan P. Lyss breaks down new data presented on immune checkpoint inhibitors in NSCLC and trastuzumab emtansine for HER2-positive breast cancer...
News
Novel chip system could improve preclinical drug studies
These chip systems could potentially reduce the use of animals and increase the efficiency of drug evaluations in preclinical studies.
Conference Coverage
PALOMA-3 biomarker analysis: Liquid biopsy could ID progression risk
TP53 mutation, FGFR1 amplification, and tumor purity in plasma each predict early progression on palbociclib and/or fulvestrant in patients with...
News
Niraparib-pembrolizumab combo finds niche in breast, ovarian cancers
The combination had good antitumor activity, as well as good safety and tolerability, in patients with advanced TNBC or ovarian carcinoma who were...